Which closed-end funds own Zealand Pharma A/S?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $3.1M. Security type: common equity. Country: Denmark. ISIN DK0060257814 · ticker ZEAL.CO.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| LGI Lazard Global Total Return & Income Fund | Multi-Asset | 0.25% | $650K | 14,663 sh | $262M | 8.0% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.19% | $2.1M | 46,920 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.06% | $319K | 7,187 sh | $573M | 3.7% discount | Jun 30, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “ZEAL.CO” → · Compare two funds’ portfolios →